Reduction of a Whole-Body Physiologically Based Pharmacokinetic Model to Stabilise the Bayesian Analysis of Clinical Data
Journal Title: The AAPS Journal - Year 2016, Vol 18, Issue 1
Abstract
The online version of this article (doi:10.1208/s12248-015-9840-7) contains supplementary material, which is available to authorized users.
Authors and Affiliations
Thierry Wendling, Nikolaos Tsamandouras, Swati Dumitras, Etienne Pigeolet, Kayode Ogungbenro, Leon Aarons
Keywords
Related Articles
- EP ID EP680829
- DOI 10.1208/s12248-015-9840-7
- Views 52
- Downloads 0
Introduction: A welcome to the first special animal health issue of AAPS PharmSci
The goal of this special volume is to provide veterinary scientists with state-of-the art reviews in animal health and to inform human health scientists of the various challenges and collaborative opportunities associate...
Recent Advances in Application of Pharmacogenomics for Biotherapeutics
Biotherapeutics (BTs), one of the fastest growing classes of drug molecules, offer several advantages over the traditional small molecule pharmaceuticals because of their relatively high specificity, low off-target effec...
Quantitative PK–PD Model-Based Translational Pharmacology of a Novel Kappa Opioid Receptor Antagonist Between Rats and Humans
Pharmacokinetic–pharmacodynamic (PK–PD) modeling greatly enables quantitative implementation of the “learn and confirm” paradigm across different stages of drug discovery and development....
Evaluation of the Biological Properties and the Enzymatic Stability of Glycosylated Luteinizing Hormone-Releasing Hormone Analogs
The online version of this article (doi:10.1208/s12248-015-9769-x) contains supplementary material, which is available to authorized users.
Influence of Surface Chemistry on Cytotoxicity and Cellular Uptake of Nanocapsules in Breast Cancer and Phagocytic Cells
The online version of this article (doi:10.1208/s12248-014-9572-0) contains supplementary material, which is available to authorized users.